The Future of Cardiology: The End of the Coronary Artery Calcium Score; Using Artificial Intelligence Phenotyping of Coronary Arteries to get a Reversible Plaque Score

George Shapiro, M.D.
Chief Medical Innovation Officer, Fountain Life
Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
Founding Partner, Cenegenics, New York City
Member, AMMG Conference Planning Committee

Current cardiovascular diagnostic approaches fail to identify patients at risk of heart attack. Symptom-driven evaluation assesses surrogates of dis-ease rather than the disease itself. The evaluation of coronary artery disease is the same as it was 50 years ago; and this approach does not reduce heart attacks. Discrimination of heart attack risk is from the type of plaque. I will reveal a new approach using artificial intelligence phenotyping as the most effective way to providing risk-guided care. Phenotype unifies and integrates the influence of all risk factors over a person’s life. Plaques that look differently behave differently. High risk plaques cause heart attacks, progress rapidly, have a poor response to medical therapy and cause ischemia. Low risk plaques do not cause heart attacks, progress slowly and are non-ischemic. Newer medical therapy treatments will also be dis-cussed for primary prevention that result in the transformation of high-risk into low-risk plaques thus stabilizing plaques reducing major adverse cardiac events.

Duration: 43m58s